ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
62 921,89
-1,28%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Anavex Life Sciences Corporation (AVXL)

  7. Anavex Life Sciences Corporation (AVXL) Actualités

AVXL Anavex Life Sciences Corporation

3,44
0,05 (1,47%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Anavex Life Sciences Corporation AVXL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,05 1,47% 3,44 01:48:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,40 3,37 3,48 3,44 3,39
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202411:45PRNUSMay 13, 2024 Deadline: Contact The Gross Law Firm to Join..
19/4/202411:45PRNUSContact The Gross Law Firm by May 13, 2024 Deadline to Join..
16/4/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/4/202411:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
11/4/202413:30GLOBEAnavex Life Sciences to Present at the Noble Capital Markets..
09/4/202411:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
05/4/202411:45PRNUSAnavex Life Sciences Corporation Class Action: The Gross Law..
02/4/202411:45PRNUSShareholders that lost money on Anavex Life Sciences..
29/3/202410:45PRNUSLost Money on Anavex Life Sciences Corporation(AVXL)? Join..
26/3/202410:45PRNUSInvestors who lost money on Anavex Life Sciences..
25/3/202412:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
22/3/202410:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
18/3/202412:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
26/2/202413:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
23/2/202412:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202413:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
01/2/202413:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
25/1/202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202413:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
16/1/202413:30GLOBEAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial..
13/1/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202413:30GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
03/1/202413:30GLOBEAnavex to Present at the 42nd Annual J.P. Morgan Healthcare..
02/1/202414:00GLOBEAnavex Life Sciences Provides an Update on Rett Syndrome..
20/12/202313:30GLOBEAnavex Announces First Entire Clinical Gene Pathway Data of..
19/12/202313:30GLOBEAnavex Received Agreement from the Committee for Medicinal..
27/11/202322:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/11/202314:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
27/11/202312:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
24/11/202314:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
22/11/202314:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
20/11/202314:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
06/11/202314:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
25/10/202314:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..
14/9/202313:30GLOBEAnavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in..
12/9/202313:30GLOBEAnavex Announces Appointment of Dr. Marwan N Sabbagh, MD as..
08/8/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Third Quarter..
07/8/202313:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
02/8/202313:30GLOBEAnavex Life Sciences to Present at the BTIG Virtual..
01/8/202313:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Third Quarter..
28/6/202313:30GLOBELong-term Clinical Study Demonstrates Disease Modifying..
27/6/202313:30GLOBEAnavex Life Sciences and Partex Group Announce Strategic..
20/6/202313:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 4th..
15/6/202313:30GLOBEANAVEX®2-73 (blarcamesine) Receives Compassionate Use..

Dernières Valeurs Consultées

NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés